Wellgistics Health, Inc. (WGRX)

Wellgistics Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-77.75	-6.86	-2.9	0.28
Depreciation & Amortization	3.06	1.11	-	0.38
Stock-Based Compensation	55.52	1.08	-	-
Other Adjustments	0.77	0.09	-	0.35
Change in Receivables	1.36	-0.04	-	-0.37
Changes in Inventories	2.32	-0.07	-	-1.82
Changes in Accounts Payable	3.69	-0.88	1.03	1.06
Changes in Accrued Expenses	2.84	1.56	1.78	-0.17
Changes in Other Operating Activities	0.5	2.77	-0.27	0.57
Operating Cash Flow	-6.86	-1.22	-0.35	0.28
Capital Expenditures	-	-	-	-0.3
Purchases of Intangible Assets	-0.74	-0.38	-	-
Purchases of Investments	-	-	-	-0.05
Other Investing Activities	0.45	0.85	-	0.22
Investing Cash Flow	-0.29	0.47	-	-0.13
Short-Term Debt Issued	21.72	2.07	-	4.75
Short-Term Debt Repaid	-13.28	-	-	-5.03
Net Short-Term Debt Issued (Repaid)	8.44	2.07	-	-0.28
Long-Term Debt Issued	1.5	-	0.35	-
Long-Term Debt Repaid	-0.27	-0.14	-	-0.68
Net Long-Term Debt Issued (Repaid)	1.23	-0.14	0.35	-0.68
Issuance of Common Stock	9.08	0.01	0	-
Net Common Stock Issued (Repurchased)	9.08	0.01	0	-
Common Dividends Paid	-	-	-	-1.72
Other Financing Activities	-1.63	-0.16	-	-
Financing Cash Flow	10.44	1.78	0.35	-2.68
Net Cash Flow	3.44	1.03	0	-2.53
Free Cash Flow	-4.2	-1.22	-0.35	-0.02
FCF Margin	-12.31%	-6.76%	-	-0.07%
Free Cash Flow Per Share	-0.07	-0.03	-0.01	-
Levered Free Cash Flow	-55.68	-0.42	0	-0.97
Unlevered Free Cash Flow	-59.74	-1.65	-0.33	-1.48

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q